Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study.

导出 OA

翻译打印收藏纠错

作者： Su Yin,Lim ^[1] ; Laura,Ferro-López ^[1] ; Elizabeth,Barquin ^[1] ; Daniel,Lindsay ^[1] ; Khin,Thway ^[1] ; Myles J,Smith ^[2] ; Charlotte,Benson ^[1] ; Robin L,Jones ^[2] ; Andrea,Napolitano ^[1]

作者单位： The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. ^[1] Institute of Cancer Research, London SW7 3RP, UK. ^[2]

关键词 GIST expanded access gastrointestinal stromal tumor real-world data ripretinib

DOI 10.3390/cancers16050985

PMID 38473346

发布时间 2024-03-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancers

2024年16卷5期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study.

Cancers

相似文献

Cancers

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study.

Cancers

相似文献

Cancers

相关期刊

检索历史清除